4//SEC Filing
GOWER BOB G 4
Accession 0001192482-21-000620
CIK 0001716947other
Filed
Jul 1, 8:00 PM ET
Accepted
Jul 2, 6:15 PM ET
Size
7.7 KB
Accession
0001192482-21-000620
Insider Transaction Report
Form 4
GOWER BOB G
Director10% Owner
Transactions
- Award
Stock Option
2021-06-30+6,585→ 6,585 totalExercise: $2.59Exp: 2029-03-14→ Common Stock (6,585 underlying) - Award
Common Stock
2021-06-30+7,919,026→ 7,919,026 total
Footnotes (2)
- [F1]On June 30, 2021, pursuant to that certain Agreement and Plan of Merger dated January 31, 2021 (the "Merger Agreement") among Ensysce Biosciences, Inc. (f/k/a Leisure Acquisition Corp.) (the "Issuer"), EB Merger Sub, Inc., a Delaware corporation and wholly-owned, direct subsidiary of the Issuer ("Merger Sub"), and Ensysce Biosciences, Inc., a Delaware corporation ("Ensysce"), Merger Sub merged with and into Ensysce (the "Merger"), with Ensysce surviving as a wholly owned subsidiary of the Issuer. Pursuant to the Merger Agreement, at the effective time of the Merger (the "Effective Time"), each share of Ensysce common stock was automatically converted into the right to receive a pro rata portion of 17,334,518 shares of the Issuer's common stock.
- [F2]Pursuant to the Merger Agreement, each option and warrant of Ensysce that was outstanding and unexercised immediately prior to the Effective Time was assumed by the Issuer (each, a "Derivative Security") and represents the right to acquire an adjusted number of shares of Common Stock at an adjusted exercise price, in each case, pursuant to the terms of the Merger Agreement.
Documents
Issuer
Ensysce Biosciences, Inc.
CIK 0001716947
Entity typeother
Related Parties
1- filerCIK 0001136466
Filing Metadata
- Form type
- 4
- Filed
- Jul 1, 8:00 PM ET
- Accepted
- Jul 2, 6:15 PM ET
- Size
- 7.7 KB